- Home
- SST vs BTMD Comparison
SST vs BTMD Comparison
Compare SST & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | BTMD |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.7M | 80.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SST | BTMD |
|---|---|---|
| Price | $4.16 | $2.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $10.00 | $6.00 |
| AVG Volume (30 Days) | 30.6K | ★ 119.4K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $289,784,000.00 | $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $3.40 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $2.90 | $2.32 |
| 52 Week High | $15.00 | $6.60 |
Technical Indicators
Market Signals| Indicator | SST | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 51.86 |
| Support Level | $4.07 | $2.58 |
| Resistance Level | $5.00 | $2.90 |
| Average True Range (ATR) | 0.43 | 0.13 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 37.12 | 51.22 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.